Cat. No. 4570
Chemical Name: 2-Bromo-N-[3-[(1-oxobutyl)amino]phe
Biological ActivityInhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50 = 0.26 μM for the inhibition of platelet P-selectin expression on human platelets). Thought to act allosterically. Also inhibits thrombin-induced platelet activation.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Dockendorff et al (2012) Discovery of 1,3-diaminobenzenes as selective inhibitors of platelet activation at the PAR1 receptor. ACS Med.Chem.Lett. 3 232. PMID: 22408714.
If you know of a relevant reference for ML 161 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses ML 161 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: ML 161, supplier, ML161, inhibitors, inhibits, protease-activated, proteinase-activated, receptors, par1, Tocris Bioscience, Protease-Activated Receptor products
Find multiple products by catalog number
New Products in this Area
Reverse analog of BradykininTASP 0390325
Potent and selective V1B receptor antagonist; orally bioavailableML 233
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonist
May 17 - 19, 2017